National Cancer Registry

National Cancer Registry (NCR)

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02AA01	CHLORHYDRATE DE MORPHINE RENAUDIN	G	Morphine HCl - 20mg/ml	20mg/ml	Injectable solution	1,100,607 L.L
C02AC05	CYNT	B	Moxonidine - 0.2mg	0.2mg	Tablet, film coated	937,444 L.L
C02AC05	CYNT	B	Moxonidine - 0.3mg	0.3mg	Tablet, film coated	1,266,372 L.L
C02AC05	CYNT	B	Moxonidine - 0.4mg	0.4mg	Tablet, film coated	1,266,372 L.L
L04AA06	CELLCEPT	B	Mycophenolate mofetil - 250mg	250mg	Capsule	6,083,575 L.L
L04AA06	CELLCEPT	B	Mycophenolate mofetil - 500mg	500mg	Tablet	6,083,575 L.L
A08AA62	CONTRAVE	B	Naltrexone Hydrochloride - 8mg, Bupropion Hydrochloride - 90mg		Tablet, prolonged release	11,653,550 L.L
S01GX09	CONJYCLEAR	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	510,660 L.L
A09AA02	CREON 25,000	B	Pancreatin protease - 1000FIP-U, Pancreatin amylase - 18000FIP-U, Pancreatin lipase - 25000FIP-U		Capsule	4,598,629 L.L
A09AA02	CREON 10,000	B	Pancreatin protease - 600FIP-U, Pancreatin amylase - 8,000FIP-U, Pancreatin lipase - 10,000FIP-U		Capsule	1,835,689 L.L
N02BE51	COQUELUSEDAL PARACETAMOL	G	Paracetamol - 100mg, Grindelia extract - 10mg, Gelsenium extract - 5mg	100mg	Suppository	598,051 L.L
N02BE01	CHILDREN'S PANADOL 5-12 YEARS	B	Paracetamol - 240mg/5ml	240mg/5ml	Elixir	356,118 L.L
N02BE51	COQUELUSEDAL PARACETAMOL	G	Paracetamol - 250mg, Grindelia extract - 20mg, Gelsenium extract - 10mg	250mg	Suppository	635,429 L.L
R05X	COLDIN-H	G	Paracetamol - 300mg, Mepyramine maleate - 15mg, Noscapine - 10mg		Capsule	386,515 L.L
R05X	COFEX	G	Paracetamol - 33.3mg/5ml, Guaifenesin - 33.3mg/5ml, Oxomemazine HCl - 1.65mg/5ml		Syrup	154,542 L.L
A03AX	COLPERMIN	B	Pepermint oil - 187mg	187mg	Capsule, delayed release	632,950 L.L
C09AA04	COVERSYL ARGININE	B	Perindopril arginine - 10mg	10mg	Tablet, film coated	452,875 L.L
C09BB04	COVERAM	B	Perindopril arginine - 10mg, Amlodipine - 10mg		Tablet	1,116,733 L.L
C09BB04	COVERAM	B	Perindopril arginine - 10mg, Amlodipine - 5mg		Tablet	1,116,733 L.L
C09BX02	COSYREL	B	Perindopril arginine - 10mg, Bisoprolol fumarate - 5mg		Tablet, film coated, scored	749,864 L.L
C09AA04	COVERSYL ARGININE	B	Perindopril arginine - 5mg	5mg	Tablet, film coated	452,875 L.L
C09BB04	COVERAM	B	Perindopril arginine - 5mg, Amlodipine - 5mg		Tablet	821,088 L.L
C09BX02	COSYREL	B	Perindopril arginine - 5mg, Bisoprolol fumarate - 5mg		Tablet, film coated, scored	749,864 L.L
N06BX03	CEBROTONIN	G	Piracetam - 800mg	800mg	Tablet, film coated	577,852 L.L
B05XA01	CHLORURE DE POTASSIUM PROAMP	G	Potassium chloride - 0.0746g/ml	0.0746g/ml	Injectable concentrated solution	1,252,461 L.L
B05XA01	CHLORURE DE POTASSIUM RENAUDIN	G	Potassium chloride - 10g/100ml	10g/100ml	Injectable solution	360,150 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE E	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 7.00g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 205.49g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE C	G	Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.33g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 204.54g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE F	G	Potassium chloride - 3.914g/l, Magnesium chloride, 6H2O - 3.558g/l, Calcium chloride, 2H2O - 7.719g/l, Acetic acid 100% - 6.010ml/l, Sodium chloride - 208.631g/l		Injectable solution	L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE SG	G	Potassium chloride - 3.92g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l		Injectable solution	L.L

...